prulifloxacin has been researched along with Pregnancy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnello, C; Cacciatore, A; Caruso, S; Cianci, A; Di Mari, L; Mammana, G | 1 |
| Ito, K; Izumi, K; Kawazoe, K; Mikamo, H; Tamaya, T | 1 |
| Fujii, S; Furukawa, S; Kikumori, M; Morinaga, T; Shindo, Y; Sumi, N; Watanabe, M; Yasuhira, K | 3 |
| Fujii, S; Kikumori, M; Morinaga, T; Nishimori, T; Okazaki, I; Shindo, Y; Sumi, N; Watanabe, M | 1 |
| Momota, K; Morino, A; Okuyama, Y | 1 |
2 trial(s) available for prulifloxacin and Pregnancy
| Article | Year |
|---|---|
[Antibiotic prophylaxis with prulifloxacin in women undergoing induced abortion: a randomized controlled trial].
Topics: Abortion, Induced; Adolescent; Adult; Antibiotic Prophylaxis; Curettage; Dioxolanes; Female; Fluoroquinolones; Gestational Age; Humans; Incidence; Parity; Pelvic Infection; Pelvic Inflammatory Disease; Piperazines; Pregnancy; Quinolones; Time Factors | 2008 |
NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
Topics: Administration, Oral; Anti-Infective Agents; Bacteria; Bacterial Infections; Dioxolanes; Female; Fluoroquinolones; Genital Diseases, Female; Genitalia, Female; Humans; Microbial Sensitivity Tests; Piperazines; Pregnancy; Quinolones | 1995 |
5 other study(ies) available for prulifloxacin and Pregnancy
| Article | Year |
|---|---|
[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(1)--A fertility study in rats by oral administration].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cecum; Dioxolanes; Drinking; Eating; Embryonic and Fetal Development; Female; Fertility; Fluoroquinolones; Kidney; Male; Organ Size; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley | 1996 |
[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(2)--A teratogenicity study in rats by oral administration].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Cecum; Dioxolanes; Drinking; Eating; Embryonic and Fetal Development; Female; Fluoroquinolones; Kidney; Male; Organ Size; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Reproduction; Weight Gain | 1996 |
[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(3)--A teratogenicity study in rabbits by oral administration].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Cecum; Dioxolanes; Drinking; Eating; Embryonic and Fetal Development; Female; Fetal Death; Fluoroquinolones; Humans; Male; Organ Size; Piperazines; Pregnancy; Quinolones; Rabbits; Reproduction; Weight Gain | 1996 |
[Reproductive and developmental toxicity studies of prulifloxacin (NM441)(4)--A perinatal and postnatal study in rats by oral administration].
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Infective Agents; Cecum; Dioxolanes; Drinking; Eating; Embryonic and Fetal Development; Female; Fluoroquinolones; Lactation; Male; Organ Size; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Reproduction; Weight Gain | 1996 |
Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
Topics: Animals; Anti-Infective Agents; Autoradiography; Biotransformation; Dioxolanes; Feces; Female; Fluoroquinolones; Liver; Male; Maternal-Fetal Exchange; Milk; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1997 |